Related Experiment Video
Updated: Apr 25, 2026
08:31
Optimized Griess Reaction for UV-Vis and Naked-eye Determination of Anti-malarial Primaquine
Published on: October 11, 2019
9.0K
4-aminoquinoline based molecular hybrids as antimalarials: an overview
Sunny Manohar, Mohit Tripathi, Diwan S Rawat1
1Department of Chemistry, University of Delhi, Delhi 110007, India. dsrawat@chemistry.du.ac.in.
Current Topics in Medicinal Chemistry
|August 14, 2014
Summary
Hybrid molecules, or dual drugs, offer a new strategy to combat drug resistance in malaria treatment. Research focuses on 4-aminoquinoline hybrids as next-generation antimalarial agents to improve chemotherapy effectiveness.
Area of Science:
- Medicinal Chemistry
- Drug Discovery
- Parasitology
Background:
- Drug resistance is a major challenge in malaria chemotherapy.
- The pharmacophoric hybridization approach offers a novel strategy for drug development.
- 4-aminoquinolines have a long history in malaria research.
Purpose of the Study:
- To review recent advances in 4-aminoquinoline-based molecular hybrids as antimalarial agents.
- To highlight the potential of these hybrids in overcoming drug resistance.
- To provide a historical perspective on 4-aminoquinolines in malaria research.
Main Methods:
- Literature review of recent advances in hybrid molecule synthesis.
- Analysis of pharmacophoric hybridization strategies.
- Examination of the development of 4-aminoquinoline antimalarials.
Main Results:
- 4-aminoquinoline-based molecular hybrids show promise as next-generation antimalarial drugs.
- Hybrid molecules are effective in overcoming existing drug resistance mechanisms.
- Recent research focuses on novel hybrid structures for enhanced efficacy.
Conclusions:
- Pharmacophoric hybridization is a viable strategy for developing new antimalarial drugs.
- 4-aminoquinoline hybrids represent a promising class of compounds for future malaria chemotherapy.
- Continued research into molecular hybrids is crucial for combating malaria.
Related Concept Videos
01:15Anthelminthic Agents
99
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
99
01:11Aryldiazonium Salts to Azo Dyes: Diazo Coupling
3.2K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
3.2K
01:28Inhibitors of Bacterial DNA Synthesis
125
Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These...
125